BGI Genomics Co., Ltd

BGI, founded in 1999 with the vision of using genomics to benefit the human race, is now the world’s largest genomics organization. In 2007, BGI’s headquarters was relocated to Shenzhen as the first citizen-managed, non-profit research institution in China.

BGI (which includes both private non-profit research institutes and sequencing application commercial units) and its affiliated offshoots, BGI Americas and BGI Europe, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, to support a variety of healthcare, agricultural, environmental and related applications.

After 15 years of development, BGI has evolved into a very broad scientific and technological organization, giving its academic and business scope global reach.

Currently, BGI comprises of 4 regions: BGI China (Mainland), BGI Asia Pacific, BGI Americas (North and South America) and BGI Europe (Europe and Africa). Relying on advanced high-throughput sequencing technology, a highly efficient data analysis capability, uniquely rich biological resources, and a multidisciplinary scientific research system, BGI can provide innovative support for global communities, novel opportunities for researchers, and a regionally tailored application services in the fields of healthcare, agriculture and the environment.

Vision

Trans-omics for a better life.

Mission

A combination of its high-throughput, cost-effective genomics platform, its large sample collection and storage capability, in-depth bioinformatics analysis, a core commitment to education and media liaison, a team of talents to support its scientific research program, has made BGI a unique entity dedicated to ensuring that omics science and technology can be made to work for the benefit of everyone.